Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Brendan Hannah Insider Profile
4 Followers
Brendan Hannah, CHIEF BUSINESS OFFICER AND COO at Quince Therapeutics, holds 201.56K shares in Quince Therapeutics (Ticker: QNCX). Most recently, Brendan Hannah Bought $71,762 shares of Quince Therapeutics on Aug 09, 2023 for an estimated value of 87.55K.
Brendan Hannah has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CHIEF BUSINESS OFFICER AND COO
Roles that Brendan Hannah holds in companies
Most Profitable Insider Trade
The most profitable trade made by Brendan Hannah
Brendan Hannah's Trading History
List of latest transactions for each holding click on a transaction to see Brendan Hannah's performance on stock
You May Also Like
Brendan Hannah insider profile FAQ
What is the percentage of profitable transactions made by Brendan Hannah?
The percentage of profitable transactions made by Brendan Hannah is ―.
What is the average return per transaction made by Brendan Hannah?
The average return per transaction made by Brendan Hannah is ―.
What stocks does Brendan Hannah hold?
Brendan Hannah holds: QNCX stocks.
What was Brendan Hannah’s latest transaction?
Brendan Hannah latest transaction was an Informative Buy of $87.55K.
What was Brendan Hannah's most profitable transaction?
Brendan Hannah’s most profitable transaction was an Informative Buy of QNCX stock on August 9, 2023. The return on the trade was -21.40%.
What is Brendan Hannah's role in Quince Therapeutics?
Brendan Hannah's role in Quince Therapeutics is CHIEF BUSINESS OFFICER AND COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.